Revisiting nocardiosis at a tertiary care institution: Any change in recent years?. (January 2021)

• Record Type: Journal Article
• Authors: Galar, Alicia; Martín-Rabadán, Pablo; Marín, Mercedes; Cercenado, Emilia; Sánchez-Carrillo, Carlos; Valerio, Maricela; Bouza, Emilio; Muñoz, Patricia
• Is Part Of: International journal of infectious diseases. Volume 102(2021)
• Page Start: 446
• Page End: 454
• Publication Date: 2021-01
• Subjects: Nocardia -- Respiratory infection -- Nocardiosis -- Opportunistic infection -- Cutaneous nocardiosis -- Central nervous system nocardiosis; Communicable diseases -- Periodicals; Communicable Diseases -- Periodicals; Communicable diseases; Periodicals; Electronic journals; 616.9
• DOI: 10.1016/j.ijid.2020.10.087
• Languages: English
• ISSNs: 1201-9712

Abstract

Highlights: Nocardiosis mainly affects elderly patients with chronic respiratory conditions and those under corticosteroid treatment. Infections in HIV and solid organ transplantation patients have practically disappeared. Nocardiosis most commonly affects the lungs. Nocardiosis caused by N. farcinica is apparently a risk factor for poor clinical outcome. Abstract: Objective: To analyse relevant changes in incidence, clinical and microbiological characteristics of nocardiosis over the last 24 years at the current institution. Materials and methods: The clinical records of patients with nocardiosis (2006–2018) were reviewed and then compared with a previous cohort (1995–2006). Nocardia isolates were identified by 5'-end-16S-rRNA-gene-PCR targeting the first 500 bp of the gene and sequencing. Susceptibility tests were determined by broth microdilution (CLSI guidelines). Results: Forty-two patients (64.3% male) with nocardiosis were evaluated in the recent cohort: 51.2% had COPD, 43.9% were on corticosteroid therapy and 31.7% had cancer. The incidence of nocardiosis varied from 6.3 to 7.1/100, 000 admissions ( p = 0.62). There was a decrease in HIV patients (27% vs. 4.9%, p = 0.01) and solid organ transplantation (SOT) recipients (18.9% vs. 2 .4%, p = 0.01). Cases with pulmonary involvement had increased (70.3% vs. 90.5%, p = 0.04). Nocardia species were similar but the most common were N. cyriacigeorgica (32.4% vs. 40.5%, p = 0.49) and N. farcinica (24.3% vs. 14.3%, p = 0.39). Antibiotic resistance remained stable: cotrimoxazole (10.8% vs. 5.7%, p = 0.68), imipenem (5.4% vs. 5.6%, p = 1.0); amikacin and linezolid were 100% active. No differences were found in breakthrough nocardiosis (21.6% vs. 9.8%, p = 0.21) or related mortality (21.6% vs. 21.4%, p = 1.0). The multivariate analysis confirmed that nocardiosis caused by N. farcinica is a risk factor for poor outcome ( p = 0.045). Conclusions: Nocardiosis incidence has remained stable. It mainly affected elderly patients with chronic respiratory conditions and those on corticosteroid treatment. Infections in HIV and SOT patients have practically disappeared. Pulmonary involvement remains the most common area to be affected. Nocardiosis caused by N. farcinica is apparently a risk factor for poor clinical outcome.